Visa comprará al líder israelí en prevención de fraude BioCatch por 24 mil millones de dólares
Visa está adquiriendo la empresa israelí de biometría conductual BioCatch por 2.4 mil millones de dólares en efectivo para reforzar las defensas globales contra el fraude digital impulsado por IA.
Valoración
Visa's $2.4 billion cash acquisition of BioCatch signals a major bet on behavioral biometrics as the frontline defense against AI-powered fraud. The deal underscores the growing strategic value of Israeli cybersecurity firms in global financial infrastructure. Watch for how Visa integrates BioCatch's technology across its payment network and whether regulators scrutinize the consolidation of fraud detection tools.